Agios Pharmaceuticals AGIO Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's quick ratio?
- Agios Pharmaceuticals (AGIO) reported quick ratio of 13.6× in Q1 2026.
- How has Agios Pharmaceuticals's quick ratio changed year-over-year?
- Agios Pharmaceuticals's quick ratio decreased by 24.2% year-over-year, from 17.9× to 13.6×.
- What is the long-term trend for Agios Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's quick ratio has grown at a 10.9% compound annual growth rate (CAGR), from 6.6× to 11.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.